Serum positive for the autoantibody against the β(1)-adrenoceptor from Chinese patients with congestive heart failure decreases I(ss) in mouse cardiac myocytes

Clin Dev Immunol. 2011:2011:143517. doi: 10.1155/2011/143517. Epub 2011 Jun 7.

Abstract

Autoantibodies targeting the β(1)-adrenergic receptor (AAB-β(1)) display agonist-like effects, which may have a pathogenic role in the progression of heart failure. Here, we used the electrophysiological recordings to explore the effects of AAB-β(1)-positive serum from Chinese patients with heart failure on the activity of the peak transient outward potassium current (I(to)) and the end 50 ms steady-state potassium current (I(ss)) in mouse cardiac myocytes. We found that the AAB-β(1)-positive serum had no effect on the activity of I(to), but it produced a decrease in the currents of I(ss). A low concentration of positive serum (1/100) had a small inhibitory effect on I(ss). However, positive serum at 1 : 10, 1 : 20, and 1 : 50 significantly decreased I(ss). The concentration-dependence analysis showed that the EC(50) of AAB-β(1)-positive serum was 1/60.24 and its nH was 2.86. It indicated that the AAB-β(1) could inhibit I(ss) in mouse cardiomyocyte in a concentration-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Animals
  • Autoantibodies / blood*
  • Autoantibodies / pharmacology*
  • China
  • Heart Failure / immunology*
  • Heart Failure / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred Strains
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology*
  • Receptors, Adrenergic, beta-1 / immunology*
  • Receptors, Adrenergic, beta-1 / metabolism

Substances

  • Autoantibodies
  • Receptors, Adrenergic, beta-1